Tilray, Inc. (TLRY) Reports Q3 Loss of $0.20, Revenues Rise 86%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Tilray, Inc. Reports Third Quarter 2018 Earnings
November 13, 2018 4:05 PM ESTRevenue rises 85.8% to $10.0 (C$12.9) million in the third quarter and 78.9% to $27.6 (C$35.5) million year-to-date Tilray medical cannabis products available to patients in 12 countries on five continents Signed agreements to supply adult-use cannabis to consumers in eight Canadian provinces and territories Completed successful $475.0 (C$610.6) million Convertible Senior Notes offering in October
NANAIMO, British Columbia--(BUSINESS WIRE)-- Tilray,Inc. (Tilray or the Company) (NASDAQ: TLRY), a global leader in cannabis production and distribution, today... More
